The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has ...
University of Delaware professor Juan Perilla (right), is co-author of a new paper that reveals a previously unknown structural role for integrase, a key HIV protein, earlier in the virus' life cycle ...
Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for remission without therapy. For years, HIV has been synonymous not only with ...
A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for ...
Genetic sequencing of peptides in rebound virus in individuals with HIV who had analytic treatment interruptions (ATIs) confirmed the peptides’ expression in HIV-1 infection, according to data ...
A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described the virus as hiding in a “latent reservoir,” a group of infected cells that ...
HONG KONG SAR - Media OutReach Newswire - 27 May 2026 - Immuno Cure Group ("Immuno Cure"), headquartered at Hong Kong Science ...
New HIV research reveals how broadly neutralizing antibodies may transform treatment despite the virus's rapid mutation and genetic diversity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results